Vioxx Heart Risk Found to Be Early and Persistent - CME Teaching Brief - MedPage Today
MONTREAL, May 3 — Vioxx (rofecoxib) attacks hearts early, not late, and its hazardous effect is sustained for seven days after treatment is stopped, according to researchers here.
The drug is now the centerpiece of hundreds of liability suits against Merck, which voluntarily pulled the Cox-2 inhibitor from the market almost two years ago.
First-time Vioxx users had a 67% increase in the risk of a myocardial infarction during the first six to 13 days of use Linda Lev�que, a doctoral fellow at the Department of Epidemiology and Biostatistics at McGill University, and colleagues, reported in an early online release for the May 23 issue of the Journal of the Canadian Medical Association.
Posted by gruwell at May 4, 2006 10:41 AM | TrackBack